Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for ...
Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the U.S. Food and Drug Administration to take action against “bad actors” selling counterfeit weight loss drugs.
Online pharmacies and private providers have been urged to “act responsibly” and ensure that the drugs are only prescribed to ...
Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority ...
Could taking tiny fractions of the normal prescribed dose of a medication offer a brilliant way to benefit from the drug, ...
Key Takeaways AbbVie agreed to license a weight-loss drug in development from Danish biotech firm Gubra.AbbVie said it will pay up to about $2.2 billion for the drug GUBamy, which is currently in a ...
The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.
A steady supply of weight-loss drugs Wegovy and Mounjaro has helped lift Eucalyptus’ revenue from $78 million to $121 million ...
Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of ...
Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results